Quick Answer
KalVista Pharmaceuticals, Inc. reported Shares Outstanding of 49.76 million shares for fiscal year 2025.
KalVista Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 49.76M | +17.0% |
| 2024 | 42.52M | +24.4% |
| 2023 | 34.17M | +39.2% |
| 2022 | 24.55M | +0.5% |
| 2021 | 24.42M | +36.9% |
| 2020 | 17.85M | +3.3% |
| 2019 | 17.28M | +60.0% |
| 2018 | 10.80M | +11.2% |
| 2017 | 9.71M | — |
| 2016 | 0 | -100.0% |
| 2015 | 26.32M | +3707.6% |
| 2014 | 691,312 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 50.54M | — | +0.4% |
| July 31, 2025 | 50.34M | +16.8% | +1.2% |
| April 30, 2025 | 49.76M | +17.0% | +0.5% |
| January 31, 2025 | 49.49M | +43.1% | +0.1% |
| December 31, 2024 | 49.43M | — | +14.2% |
| October 31, 2024 | 43.27M | +25.7% | +0.4% |
| July 31, 2024 | 43.08M | +25.7% | +1.3% |
| April 30, 2024 | 42.52M | +24.4% | +22.9% |
- KalVista Pharmaceuticals, Inc. showed an increase of +17.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, KalVista Pharmaceuticals, Inc.’s shares outstanding has grown by 7098.2% (from 691.3 thousand shares to 49.76 million shares).
- The most recent figure is from KalVista Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 10, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: